Skip to main content
logo
TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS · Delayed Price · Currency is USD
0.0055
+0.0054 (5,400.00%)
Inactive · Last trade price on Apr 1, 2026

TC Biopharm (Holdings) Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
---3.841.981.98
Revenue Growth
---94.30%0%-42.26%
Gross Profit
---3.841.981.98
Operating Income
-12.82-12.82-14.24-12.08-7.29-6.89
Net Income
-12.15-12.15-5.91-1.31-13.58-5.46
Earnings Per Share
-128.79-128.79----
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
1.221.222.464.811.570.75
Total Debt
1.51.51.82.7816.633.03
Net Cash (Debt)
-0.28-0.280.662.03-15.07-2.28
Net Cash Growth
---67.41%---
Net Cash Per Share
-3.01-3.01----

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-12.57-12.57-10.54-15.29-5.58-3.43
Capital Expenditures
-0.06-0.06-0.11-0.24-0.02-0.03
Free Cash Flow
-12.63-12.63-10.66-15.53-5.6-3.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----314.32%-368.28%-348.05%
Pretax Margin
----78.91%-757.25%-335.07%
Profit Margin
----34.17%-686.12%-275.84%
FCF Margin
----404.03%-283.07%-175.21%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
---0.63--